Literature DB >> 17149690

High prevalence of human papillomavirus 16 in penile carcinoma.

A Pascual1, M Pariente, J M Godínez, R Sánchez-Prieto, M Atienzar, M Segura, E Poblet.   

Abstract

In order to analyze the incidence and prevalence of Human Papillomavirus (HPV) in penile carcinoma, we studied 49 patients with penile carcinoma. Formalin-fixed, paraffin-embedded tissue samples were collected from 64 samples of penile carcinoma from the Hospital General Universitario (Albacete, Spain). Cases were histologically classified and the polymerase chain reaction (PCR) method was used to detect the presence of HPV. Two sets of consensus primers were used, the My09/My11, and the GP5+/GP6+. All positive cases were sequenced in order to establish the implicated genotype. Our results showed that 38 of the 49 cases were positive for HPV (77,5%). HPV16 appeared in 32 (84,2 %) of the 38 positive cases and HPV18 in 4 (10,5%). Our data demonstrate that the My09/My11 primers are more sensitive than GP5+/GP6+ primers, although the combination of the two sets of primers notably increased the total number of HPV positive cases detected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17149690     DOI: 10.14670/HH-22.177

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  9 in total

Review 1.  Genital HPV infection and related lesions in men.

Authors:  Gabriella M Anic; Anna R Giuliano
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

2.  Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas.

Authors:  Micaela Poetsch; Martin Hemmerich; Christoph Kakies; Britta Kleist; Eduard Wolf; Frank vom Dorp; Oliver W Hakenberg; Chris Protzel
Journal:  Virchows Arch       Date:  2010-11-18       Impact factor: 4.064

3.  Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation.

Authors:  Mina Kalantari; Luisa L Villa; Itzel E Calleja-Macias; Hans-Ulrich Bernard
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

4.  Histological characteristics of human papilloma-virus-positive and -negative invasive and in situ squamous cell tumours of the penis.

Authors:  Dorrit Krustrup; Helle Lone Jensen; Adriaan J C van den Brule; Morten Frisch
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

5.  The Strong Protective Effect of Circumcision against Cancer of the Penis.

Authors:  Brian J Morris; Ronald H Gray; Xavier Castellsague; F Xavier Bosch; Daniel T Halperin; Jake H Waskett; Catherine A Hankins
Journal:  Adv Urol       Date:  2011-05-22

6.  Elimination of Cancer Health Disparities through the Acceleration of HPV Vaccines and Vaccinations: A Simplified Version of the President's Cancer Panel Report on HPV Vaccinations.

Authors:  Eva McGhee; Hill Harper; Adaku Ume; Melanie Baker; Cheick Diarra; John Uyanne; Sebhat Afework; Keosha Partlow; Lucy Tran; Judith Okoro; Anh Doan; Karen Tate; Mechelle Rouse; Meidrah Tyler; Kamilah Evans; Tonya Sanchez; Ishmum Hasan; Enijah Smith-Joe; Jasmine Maniti; Liliana Zarate; Camille King; Antoinette Alugbue; Chiamaka Opara; Bileko Wissa; Joanne Maniti; Roland Pattillo
Journal:  J Vaccines Vaccin       Date:  2017-05-29

7.  The relationship between human papillomavirus and penile cancer over the past decade: a systematic review and meta-analysis.

Authors:  Yong-Bo Yu; Yong-Hua Wang; Xue-Cheng Yang; Yang Zhao; Mei-Lan Wang; Ye Liang; Hai-Tao Niu
Journal:  Asian J Androl       Date:  2019 Jul-Aug       Impact factor: 3.285

8.  Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma.

Authors:  D M Prowse; E N Ktori; D Chandrasekaran; A Prapa; S Baithun
Journal:  Br J Dermatol       Date:  2007-11-28       Impact factor: 9.302

Review 9.  Epigenetic mechanisms in penile carcinoma.

Authors:  Hellen Kuasne; Fabio Albuquerque Marchi; Silvia Regina Rogatto; Ilce Mara de Syllos Cólus
Journal:  Int J Mol Sci       Date:  2013-05-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.